TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
LLY

Eli Lilly and Company

Healthcare · Drug Manufacturers - General

1,183.50$ +0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Eli Lilly and Company (LLY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 16,813 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow LLY
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1,991 2,400 2,630 2,620 3,732 3,662 2,071 3,647 2,870 1,914 3,976 5,155 7,296 4,336 6,857 7,235 5,305 5,735 4,458 2,965 4,851 5,616 5,525 4,837 6,500 7,261 7,084 4,240 8,818 16,813
544 510 490 440 436 455 493 549 598 726 802 1,048 1,123 1,298 1,328 1,374 1,462 1,446 1,379 1,428 1,497 1,567 1,609 1,233 1,324 1,548 1,523 1,527 1,767 1,997
– 2,126 -7.2 – – – – – – 404 359 282 255 369 231 147 142 145 156 218 255 281 280 312 308 343 371 629 646 626
– – – – – – – – – – – – – – 791 – -195 – 506 -145 1,101 1,048 3,062 653 -271 1,154 -668 – – –
-185 480 109 -426 778 -77 -1,542 84 -1,238 -1,947 -795 -117 2,348 -957 -186 1,248 -51 -393 484 -1,139 -484 3,205 -2,379 -1,687 -747 -1,023 -15 -3,055 -5,385 -8,093
444 366 420 528 678 884 1,131 1,707 1,898 1,298 1,078 1,082 947 855 1,187 1,693 1,044 1,093 1,566 1,626 1,092 2,164 3,018 1,354 2,029 1,873 2,484 7,392 8,404 7,841
-468 810 -294 1,087 -1,057 -3,965 -2,474 -1,332 -685 -2,216 608 -4,328 -7,269 143 -3,160 -4,824 -2,833 -2,073 -3,909 27 -3,139 -3,784 1,906 -8,083 -2,259 -2,868 -3,763 -7,153 -9,302 -10,972
753 818 878 1,001 1,126 1,207 1,336 1,443 1,540 1,655 1,736 1,854 2,057 2,152 2,165 2,180 2,187 2,121 2,101 2,127 2,159 2,192 2,312 2,410 2,687 3,087 3,536 4,069 4,680 5,384
-315 -351 -2,173 -1,453 -1,053 -546 -385 -281 – -378 -122 – – 0.0 0.0 0.0 -721 -1,698 -800 -750 -600 -300 -4,151 -4,400 -500 -1,250 -1,500 -750 -2,500 -4,108
– – – – – – – – – – – – – – 124 – -1,511 – 2,639 -182 2,500 2,999 -729 4,685 292 501 -62 8,650 8,901 8,051
-1,661 -1,955 -2,813 -1,453 -2,230 -1,049 -422 -1,578 204 -1,881 -4,579 -845 2,346 -5,534 -2,022 -2,370 -4,420 -3,829 -166 -2,919 -560 143 -5,905 -2,325 -3,137 -4,131 -5,407 3,496 1,230 -2,213
-186 1,134 -452 2,205 415 -1,413 -756 810 2,609 -2,359 103 111 2,276 -1,034 1,530 -71 -1,904 -189 41 -205 916 1,954 1,462 -5,661 1,320 161 -1,752 752 450 4,000
1,548 2,034 2,210 2,091 3,054 2,778 940 1,940 971 616 2,898 4,072 6,348 3,481 5,670 5,542 4,261 4,642 2,893 1,338 3,759 3,452 2,506 3,483 4,471 5,388 4,600 -3,152 414 8,972

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?